JAMA Medical News cover image

What's Next in Weight-Loss Drugs?

JAMA Medical News

00:00

High‑dose semaglutide trial outcomes

Rita reports 7.2 mg semaglutide produced about 21% weight loss versus 17.5% with 2.4 mg at 72 weeks.

Play episode from 02:22
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app